The FDA authorized COVID-19 vaccine for children under 5 years; more than 400,000 over-the-counter (OTC) medications were recalled; medication imports from Canada and the United Kingdom see bipartisan approval in the Senate.
FDA Approves COVID-19 Vaccine for Children Under 5
The FDA approved both the Moderna and Pfizer COVID-19 vaccines for use in children under the age of 5 years on Friday, according to a press release. The move comes 18 months after the first vaccines were made available to the general public. The approval by the FDA follows the unanimous recommendation from the advisory panel to the FDA. An advisory panel to the CDC is set to meet on Friday and Saturday before CDC Director Rochelle P. Walensky, MD, MPH, will issue a recommendation, which is the final step before vaccine rollout begins. Pfizer claims that its vaccine is 80% effective when 3 doses are taken.
400,000 Over-The-Counter Medications Recalled
The recall of more than 400,000 bottles of over-the-counter medicine was announced by the Consumer Product Safety Commission on Thursday. The recalled medications include 137,300 units of Walgreens brand acetaminophen, 25,660 units of Kroger brand arthritis pain acetaminophen, 209,430 units of Kroger brand aspirin and ibuprofen, and 34,660 units of Kroger brand acetaminophen, according to The Hill. These medications were recalled due to their packaging not receiving child-proofing methods, making them a hazard to children who may swallow the contents. Product recalls are set to reach record numbers in the United States this year, with one report finding that companies had recalled more than 900 million product units in the first 3 months of 2022.
Importing Medication from Canada and United Kingdom Sees Bipartisan Support
Senator Bernie Sanders, I-Vermont, proposed that an amendment to allow importation of medication from Canada and the United Kingdom—and other countries after 2 years—in a bill aimed at reauthorizing the FDA’s user fee program that’s set to expire on September 30. The amendment has received support from Senator Rand Paul, R-Kentucky, according to Kaiser Health News. The amendment would allow medications such as insulin to be imported from other countries, where medication is often sold for less. However, the amendment was tabled and will not be included in the final FDA user fee bill.
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Survey Results Reveal Potential Factors Slowing the Decline in Cardiovascular Mortality Rate
April 23rd 2024Research indicated that worsened glycemic, blood pressure, and obesity control, as well as increased alcohol consumption, leveled lipid control, and persistent socioeconomic disparities may have contributed to the decelerated cardiovascular mortality decline in recent years.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More